Join the Oncology Voice Network. Join for Free
MSL Training: The Path of Continued Learning and Development
MSL training medical science liaison skills soft skills in healthcare operational training for MSLs career transition for MSLs

MSL Training: The Path of Continued Learning and Development


Share This Article


Summary

In this episode, Michael Parisi and Marissa Polly from GuideMark Health join to explore the evolving training needs of Medical Science Liaisons (MSLs). They discuss the essential scientific and clinical skills required, alongside strategies for reengaging field medical teams post-COVID. The conversation highlights the importance of soft skills and empathy in MSL success, and offers insights into enhancing operational training and territory management. Michael and Marissa also address the challenges new MSLs face during career transitions, inviting listener input. The episode concludes with closing remarks and a note of appreciation, with GuideMark Health as the sponsor.

Check out my latest podcast with Michael Parisi and Marissa Poli of Guidemark Health as we cover MSL Training: The Path of Continued Learning and Development.

We discuss:

 Core Competency-Scientific and Clinical Training
 Soft Skills and Empathy Training
 Operational Skills in a Virtual World
 Career On Ramp Training

Click for Source
MSL training, medical science liaison skills, soft skills in healthcare, operational training for MSLs, career transition for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Podcast
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Partner Avatar MSL Talk: Tom Caravela, John Caskey

Prepare to LAUNCH: How to Build an MSL Team From Scratch

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN